Improved blood flow: GLP1 therapies could support cerebral circulation and energy metabolism
View Source Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie Melanotan-II reverses memory impairment induced by a short-term HF diet 2023 DOI: 10.1016/j.biopha.2023.115129 PMID: 37478579 Wekwejt P, Wojda U, Kiryk A View Source Dermatology (Basel, Switzerland) Melanotan II User Experience: A Qualitative Study of Online Discussion Forums 2021 DOI: 10.1159/000514492 PMID: 34464955 Gilhooley E, Daly S, McKenna D View Source Neuropeptides Melanocortin receptor agonist melanotan-II microinjected in the nucleus accumbens decreases appetitive and consumptive responding for food 2022 DOI: 10.1016/j.npep.2022.102289 PMID: 36155088 Eliason NL, Martin L, Low MJ, et al
Some may notice their appetite changing within the first few weeks, while others may start seeing weight loss by the first month, with overall results typically happening over the first year of treatment
A review on caspases: key regulators of biological activities and apoptosis
10.4067/S0717-75182015000200014 Rev